Affimed - Stock Price History | AFMD

Historical daily share price chart and data for Affimed since 2021 adjusted for splits. The latest closing stock price for Affimed as of September 23, 2021 is 6.59.
  • The all-time high Affimed stock closing price was 21.93 on July 17, 2015.
  • The Affimed 52-week high stock price is 11.74, which is 78.1% above the current share price.
  • The Affimed 52-week low stock price is 3.08, which is 53.3% below the current share price.
  • The average Affimed stock price for the last 52 weeks is 6.69.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Affimed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.4254 2.6500 7.0300 1.4400 5.8200 112.41%
2019 3.1473 3.2200 4.3400 2.2500 2.7400 -11.90%
2018 2.6397 1.3750 6.1500 1.2500 3.1100 139.23%
2017 2.1198 2.1000 2.7500 1.2250 1.3000 -27.78%
2016 3.0924 6.6900 6.6900 1.8000 1.8000 -74.72%
2015 8.7666 6.2400 21.9300 5.1800 7.1200 14.84%
2014 5.7853 5.7000 7.8300 4.1120 6.2000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.623B $0.032B
Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V., is based in Heidelberg, Germany.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71